NECT Is Next: Implementing the New Drug Combination Therapy for Trypanosoma brucei gambiense Sleeping Sickness

How to Shorten Patient Follow‐Up after Treatment forTrypanosoma brucei gambienseSleeping Sickness

(2010) Dieudonné Mumba Ngoyi et al.   JOURNAL OF INFECTIOUS DISEASES

Integration of control of neglected tropical diseases into health-care systems: challenges and opportunities

(2010) John O Gyapong et al.   LANCET

Eflornithine is a cost-effective alternative to melarsoprol for the treatment of second-stage human West African trypanosomiasis in Caxito, Angola

(2010) J. Robays et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

NECT trial: more than a small victory over sleeping sickness

(2009) Jimmy Opigo et al.   LANCET

Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial

(2009) Gerardo Priotto et al.   LANCET

Human African trypanosomiasis

(2009) Reto Brun et al.   LANCET

New treatment for sleeping sickness still not implemented

(2009) Kelly Morris   LANCET INFECTIOUS DISEASES

Eliminating Human African Trypanosomiasis: Where Do We Stand and What Comes Next?

(2008) Pere P Simarro et al.   PLOS MEDICINE